Matrix Laboratories

                   

Mylan swings to 2Q loss on acquisition costs (AP)

yahoo.com     yesterday   5 related          

Wednesday August 6, 8:48 am ET Mylan takes 2nd-quarter loss, but sales more than double after Merck generic buyout PITTSBURGH (AP) -- Generic drug maker Mylan Inc. said Wednesday it swung to a loss after buying the generics...                    

comments

                   

Stocks in news: NTPC, Godrej Ind, Rolta

moneycontrol.com     Jul 29, 2008          

Published on Tue, Jul 29 at 08:37 , Updated at Tue, Jul 29 at 08:39 Source : moneycontrol.com Results Today: NTPC, GAIL, Cairn India, Ranbaxy, HPCL, Hero Honda, Jet Airways, BoB, Ashok Leyland, GMR Infra, Praj Industries, Punj...                    

comments

                   

Pharma cos record 26% growth in profits, sales up by 17% during 2007-08

pharmiweb.co.uk     Jul 21, 2008   192 related          

Sanjay Pingle, Mumbai The top 75 pharmaceutical companies in India have reported impressive growth in sales and profits during the year ended March 2008 despite adverse market conditions in the domestic and international...                    

comments

Sector Snap: Teva-Barr talk lifts generics makers

ibtimes.com     Jul 17, 2008   224 related          

NEW YORK (AP) - Shares of Barr Pharmaceuticals Inc. soared Thursday on reports of buyout talks between Barr and industry leader Teva Pharmaceutical Industries Ltd., lifting shares of other generic drug makers. Citing market...                    

comments

Indian Generic Drug Companies, HIV/AIDS Advocacy Group File Opposition To Patent Of Roche's...

medicalnewstoday.com     Jul 2, 2008   7 related          

Indian generic pharmaceutical companies Cipla and Matrix Laboratories and the HIV/AIDS advocacy group Delhi Network of Positive People, or DNP+, recently filed an objection to an Indian patent office's decision to give a patent...                    

comments

Matrix board approves MD appointment

thehindubusinessline.com     Jul 1, 2008          

Hyderabad, July 1 The board of Matrix Laboratories Ltd has approved the appointment of Mr Jagdish Viswanath Dore as Managing Director of the company, effective July 1, 2008. In other decisions approved by the board of directors...                    

comments

Stocks in news: TVS Motor, South Indian Bk, Core Projects

moneycontrol.com     Jun 30, 2008          

Results today: Akruti City, Ansal Housing, Ansal Properties, Aries Agro, Ashapura Minechem, Atlanta, Balaji Telefilms, Bannari Amman Spinning, BEML, Bharati Shipyard, Bombay Dyeing, Bombay Rayon, Broadcast Initiatives, Deccan...                    

comments

Matrix Laboratories gains smartly

moneycontrol.com     Jun 30, 2008          

At 12:57 pm, Matrix Laboratories was quoting at Rs 147, up Rs 5.75, or 4.07%. It has touched an intraday high of Rs 149 and an intraday low of Rs 140.30. It was trading with volumes of 23,683 shares. On Friday the share closed...                    

comments

                   
livemint.com: Done deal: Ranbaxy chief Malvinder Singh with Daiichi Sankyo’s Takashi Shoda. (Harikrishna Katragadda / Mint) livemint.com

First Ranbaxy, analysts wonder who's next?

theglobeandmail.com     Jun 12, 2008   387 related          

HIRAL VORA AND BHARGHAVI NAGARAJU MUMBAI — Daiichi Sankyo's $4.6-billion (U.S.) bid for control of India's Ranbaxy Laboratories Ltd could be the trigger for foreign pharmaceutical companies to step up the hunt for low-cost...                    

comments

Mylan ties up for Natcos syringes

expressindia.com     Jun 10, 2008   34 related          

Waving a threat signal to the generic leader Teva Pharmaceuticals, the US-based Mylan Inc has signed a license and supply agreement with Hyderabad-based Natco Pharma Ltd for Natco's glatiramer acetate pre-filled syringes, which...                    

comments

1 2 3 4 5 next »